These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Genital ulcers and concomitant complaints in men attending a sexually transmitted infections clinic: implications for sexually transmitted infections management. O'Farrell N, Morison L, Moodley P, Pillay K, Vanmali T, Quigley M, Sturm AW. Sex Transm Dis; 2008 Jun; 35(6):545-9. PubMed ID: 18356769 [Abstract] [Full Text] [Related]
30. Efficacy of a dish detergent in reducing populations of STI organisms in inoculated female condoms. Joanis C, Lopez LM, Gomez K, Ramm K, Rottjakob D. Int J STD AIDS; 2007 Mar; 18(3):198-201. PubMed ID: 17362555 [Abstract] [Full Text] [Related]
33. Impact of microbicides and sexually transmitted infections on mucosal immunity in the female genital tract. Keller MJ, Herold BC. Am J Reprod Immunol; 2006 Mar; 56(5-6):356-63. PubMed ID: 17076680 [Abstract] [Full Text] [Related]
34. [Sexual abuse in children: prevention of sexually transmitted diseases]. García Algar O, Mur Sierra A. An Esp Pediatr; 2001 Mar; 54(3):267-71. PubMed ID: 11262256 [Abstract] [Full Text] [Related]
35. Porphyrin-based compounds exert antibacterial action against the sexually transmitted pathogens Neisseria gonorrhoeae and Haemophilus ducreyi. Bozja J, Yi K, Shafer WM, Stojiljkovic I. Int J Antimicrob Agents; 2004 Dec; 24(6):578-84. PubMed ID: 15555881 [Abstract] [Full Text] [Related]
36. A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety. Galen BT, Martin AP, Hazrati E, Garin A, Guzman E, Wilson SS, Porter DD, Lira SA, Keller MJ, Herold BC. J Infect Dis; 2007 May 01; 195(9):1332-9. PubMed ID: 17397004 [Abstract] [Full Text] [Related]
37. Nonactivated titanium-dioxide nanoparticles promote the growth of Chlamydia trachomatis and decrease the antimicrobial activity of silver nanoparticles. Bogdanov A, Janovák L, Lantos I, Endrész V, Sebők D, Szabó T, Dékány I, Deák J, Rázga Z, Burián K, Virok DP. J Appl Microbiol; 2017 Nov 01; 123(5):1335-1345. PubMed ID: 28799270 [Abstract] [Full Text] [Related]
38. The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model. Bourne N, Bernstein DI, Ireland J, Sonderfan AJ, Profy AT, Stanberry LR. J Infect Dis; 1999 Jul 01; 180(1):203-5. PubMed ID: 10353881 [Abstract] [Full Text] [Related]
39. Virological, serological and epidemiological study of 255 consecutive cases of genital herpes in a sexually transmitted disease clinic of Paris (France): a prospective study. Janier M, Scieux C, Méouchi R, Tournoux C, Porcher R, Maillard A, Fouéré S, Taquin Y, Lassau F, Morel P. Int J STD AIDS; 2006 Jan 01; 17(1):44-9. PubMed ID: 16409679 [Abstract] [Full Text] [Related]
40. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae. Matsumoto T. Int J Antimicrob Agents; 2008 Feb 01; 31 Suppl 1():S35-9. PubMed ID: 18164598 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]